Login / Signup

Patients' Acceptance of COVID-19 Vaccine: Implications for Patients with Chronic Disease in Low-Resource Settings.

Firomsa BekeleGinenus FekaduTarekegn Fekede WoldeLemessa Wakgari Bekelcho
Published in: Patient preference and adherence (2021)
Coronavirus disease 2019 (COVID-19) has become a major global health challenge, with high morbidity and mortality. Despite different vaccines being produced around the globe, the spread of the virus is still uncontrolled. In particular, the shortage of vaccines in low-income countries is one of the key factors hindering efforts to reduce the spread of the virus. Even though evidence has been provided by different responsible bodies, there are still multiple beliefs and misconceptions about COVID-19 vaccination that have not yet been addressed. Nowadays, vaccine hesitancy is one of the top ten threats to global health, arising from the unwillingness of chronic patients to receive the vaccine. Chronic disease patients in low-resource settings are fearful of taking the vaccine because of a shortage of information about the COVID-19 vaccine. Therefore, the acceptance of the COVID-19 vaccine among chronic disease patients should be studied more widely in low-resource settings.
Keyphrases
  • coronavirus disease
  • end stage renal disease
  • sars cov
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • global health
  • healthcare
  • patient reported outcomes
  • patient reported
  • drug induced